Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Leap Therapeutics Inc.

    NASDAQ: LPTX · Real-Time Price · USD
    0.39
    -0.01 (-1.32%)
    At close: Jun 06, 2025, 3:59 PM
    0.40
    1.83%
    After-hours: Jun 06, 2025, 05:39 PM EDT

    Leap Therapeutics Statistics

    Share Statistics

    Leap Therapeutics has 41.44M shares outstanding. The number of shares has increased by 7.82% in one year.

    Shares Outstanding

    n/a
    		 41.44M

    Shares Change (YoY)

    n/a
    		 7.82%

    Shares Change (QoQ)

    n/a
    		 7.67%

    Owned by Institutions (%)

    n/a
    		 51.49%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4,928

    FTD / Avg. Volume

    n/a
    		 0.23%

    Short Selling Information

    The latest short interest is 1.89M, so 4.56% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.89M

    Short % of Shares Out

    n/a
    		 4.56%

    Short % of Float

    n/a
    		 5.35%

    Short Ratio (days to cover)

    n/a
    		 6.24

    Valuation Ratios

    The PE ratio is -1.6 and the forward PE ratio is -0.75. Leap Therapeutics's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.6

    Forward PE

    n/a
    		 -0.75

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 3.09

    P/FCF Ratio

    n/a
    		 -1.79

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Leap Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 3.41

    Quick Ratio

    n/a
    		 3.41

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,299,134.62

    Employee Count

    n/a
    		 52

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 585K

    Effective Tax Rate

    n/a
    		 -0.87%

    Stock Price Statistics

    The stock price has increased by -82.59% in the last 52 weeks. The beta is -0.22, so Leap Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.22

    52-Week Price Change

    n/a
    		 -82.59%

    50-Day Moving Average

    n/a
    		 0.36

    200-Day Moving Average

    n/a
    		 1.77

    Relative Strength Index (RSI)

    n/a
    		 52.16

    Average Volume (20 Days)

    n/a
    		 2,143,787

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -70.06M

    Net Income

    n/a
    		 -67.56M

    EBITDA

    n/a
    		 -66.97M

    EBIT

    n/a
    		 -66.97M

    Earnings Per Share (EPS)

    n/a
    		 -1.81
    Full Income Statement

    Balance Sheet

    The company has 47.25M in cash and 266K in debt, giving a net cash position of 46.98M.

    Cash & Cash Equivalents

    n/a
    		 47.25M

    Total Debt

    n/a
    		 266K

    Net Cash

    n/a
    		 46.98M

    Retained Earnings

    n/a
    		 -467.37M

    Total Assets

    n/a
    		 34.88M

    Working Capital

    n/a
    		 19.83M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -60.3M and capital expenditures 0, giving a free cash flow of -60.3M.

    Operating Cash Flow

    n/a
    		 -60.3M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -60.3M

    FCF Per Share

    n/a
    		 -1.61
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    LPTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LPTX is $8, which is 1951.3% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 1951.3%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 21, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jun 21, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -24.79

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist